Janssen Pharmaceutical

Dr. Pim Drinkenburg / Dr. John Kemp

Caring for the world, one person at a time’... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. 

Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Janssen Pharmaceutica is one of the most innovative pharmaceutical companies in the world. Our research develops products for a range of disease areas, such as mental disorders, neurological problems, infectious diseases, immunological disorders, cancer, and cardiovascular and metabolic conditions.

Group description

The M-Gate project is embedded in the Neuroscience Discovery Department of Janssen R&D (Belgium), where scientists work together to identify transformational therapies for neurodegenerative disorders. The implementation of state-of the-art translational neurophysiological technologies and methods are an instrumental part of that effort to discover new therapies.

People: Dr. W.H.I.M. (Pim) Drinkenburg, Scientific Director & Fellow – P.I. & Dr John Kemp, Head of Neuroscience Discovery Biology, Beerse (B)  

Links: Janssen research 

ESR 15 : Sean Tok